News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,766 Results
Type
Article (40473)
Company Profile (253)
Press Release (662040)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204977)
Career Advice (2025)
Deals (35473)
Drug Delivery (96)
Drug Development (81198)
Employer Resources (172)
FDA (16228)
Job Trends (14928)
News (346307)
Policy (32644)
Tag
Academia (2600)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49741)
ALS (93)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (132)
Approvals (16225)
Artificial intelligence (261)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11664)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (180)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (289)
Cancer (2306)
Cardiovascular disease (179)
Career advice (1690)
Career pathing (31)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (66152)
Collaboration (854)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2606)
CRISPR (41)
C-suite (251)
Cystic fibrosis (101)
Data (2298)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6406)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87062)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112992)
Executive appointments (739)
FDA (17591)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (109)
Generative AI (19)
Gene therapy (309)
GLP-1 (716)
Government (4452)
Grass and pollen (4)
Guidances (150)
Healthcare (18850)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (121)
Indications (29)
Infectious disease (2751)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (315)
IPO (16538)
IRA (40)
Job creations (3670)
Job search strategy (1435)
Kidney cancer (10)
Labor market (43)
Layoffs (478)
Leadership (18)
Legal (7927)
Liver cancer (77)
Lung cancer (324)
Lymphoma (156)
Machine learning (9)
Management (58)
Manufacturing (323)
MASH (74)
Medical device (13414)
Medtech (13419)
Mergers & acquisitions (19501)
Metabolic disorders (703)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1932)
NextGen: Class of 2025 (6532)
Non-profit (4509)
Now hiring (40)
Obesity (371)
Opinion (204)
Ovarian cancer (80)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57643)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20632)
Phase II (29134)
Phase III (21685)
Pipeline (1345)
Policy (147)
Postmarket research (2568)
Preclinical (8784)
Press Release (68)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (382)
Real estate (5968)
Recruiting (65)
Regulatory (22383)
Reports (47)
Research institute (2361)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (132)
Series B (88)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3603)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (49)
The Weekly (30)
Vaccines (701)
Venture capitalists (42)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Today (170)
Last 7 days (945)
Last 30 days (3066)
Last 365 days (32586)
2025 (11666)
2024 (35264)
2023 (40140)
2022 (51244)
2021 (55810)
2020 (54208)
2019 (46687)
2018 (35176)
2017 (32279)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (722)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38109)
Australia (6227)
California (6371)
Canada (2058)
China (533)
Colorado (271)
Connecticut (278)
Delaware (157)
Europe (81885)
Florida (946)
Georgia (213)
Idaho (57)
Illinois (545)
India (25)
Indiana (318)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (920)
Massachusetts (4732)
Michigan (223)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1784)
New Mexico (28)
New York (1794)
North Carolina (985)
North Dakota (8)
Northern California (2803)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1416)
Puerto Rico (13)
Rhode Island (33)
South America (1106)
South Carolina (25)
South Dakota (1)
Southern California (2401)
Tennessee (106)
Texas (947)
United States (23873)
Utah (188)
Virginia (154)
Washington D.C. (64)
Washington State (561)
West Virginia (3)
Wisconsin (56)
702,766 Results for "aruna biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Genetown
Aruna Bio to Participate in Upcoming Investor Conferences
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at upcoming investor conferences.
March 18, 2024
·
1 min read
Business
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, announced the appointment of Lynn Swann to its Board of Directors.
June 3, 2024
·
2 min read
BioMidwest
Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative diseases, is pleased to announce the formation of its Stroke Advisory Board.
March 4, 2024
·
4 min read
Genetown
Aruna Bio to Participate in the BIO Investor Forum in October 2023
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the BIO Investor Forum being held October 17-18, 2023, in San Francisco, CA.
October 10, 2023
·
1 min read
Press Releases
Impact BioMedical Inc. to Present at The Microcap Conference
January 23, 2025
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
·
2 min read
Genetown
Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication
Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program, AB126.
January 16, 2024
·
3 min read
1 of 70,277
Next
